Item Type | Name |
Concept
|
Allergy and Immunology
|
Concept
|
Hypersensitivity
|
Concept
|
Drug Hypersensitivity
|
Concept
|
Respiratory Hypersensitivity
|
Concept
|
Hypersensitivity, Immediate
|
Concept
|
National Institute of Allergy and Infectious Diseases (U.S.)
|
Concept
|
Hypersensitivity, Delayed
|
Academic Article
|
Effects of loratadine and terfenadine on the induced nasal allergic reaction.
|
Academic Article
|
Inhibition of mediator release during the early reaction to antigen.
|
Academic Article
|
Pathophysiology of perennial allergic rhinitis.
|
Academic Article
|
A double-blind study of the discontinuation of ragweed immunotherapy.
|
Academic Article
|
Origin of late phase histamine release.
|
Academic Article
|
Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction.
|
Academic Article
|
Relationship between histamine and physiological changes during the early response to nasal antigen provocation.
|
Academic Article
|
Complications of sinusitis.
|
Academic Article
|
The impact of immunotherapy on the pathophysiology of ragweed pollen allergy.
|
Academic Article
|
Sinusitis: bench to bedside. Current findings, future directions.
|
Academic Article
|
Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2.
|
Academic Article
|
Total IgE serum levels correlate with sinus mucosal thickness on computerized tomography scans.
|
Academic Article
|
Optimizing treatment options.
|
Academic Article
|
Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide.
|
Academic Article
|
Nasal provocation with allergen induces a secondary serum IgE antibody response.
|
Academic Article
|
Treatment with hot, humid air reduces the nasal response to allergen challenge.
|
Academic Article
|
Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype.
|
Academic Article
|
Antiallergic effects of H1-receptor antagonists.
|
Academic Article
|
Additional properties of cetirizine, a new H1 antagonist.
|
Academic Article
|
Understanding the inflammatory processes in upper allergic airway disease and asthma.
|
Academic Article
|
Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge.
|
Academic Article
|
Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen.
|
Academic Article
|
Dose-dependent effects of intranasal steroids: how relevant?
|
Academic Article
|
Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine.
|
Academic Article
|
Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine.
|
Academic Article
|
Comparison of the response to histamine challenge of the nose and the maxillary sinus: effect of loratadine.
|
Academic Article
|
Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps.
|
Academic Article
|
Clinical manifestations of the release of histamine and other inflammatory mediators.
|
Academic Article
|
Airways, allergy, sinus.
|
Academic Article
|
Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy.
|
Academic Article
|
Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen.
|
Academic Article
|
Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions.
|
Academic Article
|
Allergic inflammation enhances bacterial sinusitis in mice.
|
Academic Article
|
Effects of fexofenadine on the early response to nasal allergen challenge.
|
Academic Article
|
Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
|
Academic Article
|
Natural and induced allergic responses increase the ability of the nose to warm and humidify air.
|
Academic Article
|
Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen.
|
Academic Article
|
The nasal allergic reaction: observations on the role of histamine.
|
Academic Article
|
Increased nasal airflow with budesonide compared with desloratadine during the allergy season.
|
Academic Article
|
Desloratadine partially inhibits the augmented bacterial responses in the sinuses of allergic and infected mice.
|
Academic Article
|
The role of histamine in allergic rhinitis.
|
Academic Article
|
Role of allergy in rhinosinusitis.
|
Academic Article
|
Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells.
|
Academic Article
|
Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA).
|
Academic Article
|
Persistent inflammation and hyperresponsiveness following viral rhinosinusitis.
|
Academic Article
|
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).
|
Academic Article
|
Total IgE levels do not change 1 year after endoscopic sinus surgery in patients with chronic rhinosinusitis.
|
Academic Article
|
Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity.
|
Academic Article
|
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
|
Academic Article
|
Histamine stimulation of the nasal mucosa does not induce prostaglandin or leukotriene generation or induce methacholine hyperresponsiveness.
|
Academic Article
|
Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.
|
Academic Article
|
Cold air-induced rhinitis.
|
Academic Article
|
Allergic rhinitis augments the response to a bacterial sinus infection in mice: A review of an animal model.
|
Academic Article
|
Environmental and allergic factors in chronic rhinosinusitis.
|
Academic Article
|
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).
|
Academic Article
|
Nasal challenge with allergen leads to maxillary sinus inflammation.
|
Academic Article
|
Antigen stimulation of TH2 cells augments acute bacterial sinusitis in mice.
|
Academic Article
|
Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy.
|
Academic Article
|
Mediator release after allergic and physical nasal challenges.
|
Academic Article
|
Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis.
|
Academic Article
|
Patient and physician perspectives on the attributes of nasal allergy medications.
|
Academic Article
|
Rhinosinusitis: establishing definitions for clinical research and patient care.
|
Academic Article
|
Attenuation of allergen sensitivity early in the course of ragweed immunotherapy.
|
Academic Article
|
Observations on the pathogenesis of nasal priming.
|
Academic Article
|
Rhinosinusitis: developing guidance for clinical trials.
|
Academic Article
|
Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis?
|
Academic Article
|
Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo.
|
Academic Article
|
In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease.
|
Academic Article
|
The congestion quantifier five-item test for nasal congestion: refinement of the congestion quantifier seven-item test.
|
Academic Article
|
Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.
|
Academic Article
|
Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids.
|
Academic Article
|
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.
|
Academic Article
|
Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial.
|
Academic Article
|
Responses to ragweed-pollen nasal challenge before and after immunotherapy.
|
Academic Article
|
Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.
|
Academic Article
|
Theophylline reduces histamine release during pollen-induced rhinitis.
|
Academic Article
|
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
|
Academic Article
|
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.
|
Academic Article
|
The role of kinins in human allergic disease.
|
Academic Article
|
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis.
|
Academic Article
|
Is leukotriene B4 an important mediator in human IgE-mediated allergic reactions?
|
Academic Article
|
The pathophysiology of allergic rhinitis: impact of therapeutic intervention.
|
Academic Article
|
The pathophysiology of human mast cells. In vitro and in vivo function.
|
Academic Article
|
Pharmacology of upper airways challenge.
|
Academic Article
|
Introduction: insights into the upper airway for pulmonologists and allergists.
|
Academic Article
|
An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis.
|
Academic Article
|
The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine.
|
Academic Article
|
Kinins as mediators of human allergic reactions.
|
Academic Article
|
Influx of kininogens into nasal secretions after antigen challenge of allergic individuals.
|
Academic Article
|
The effect of azelastine on the early allergic response.
|
Academic Article
|
The effects of H1 antihistamines on the early allergic response.
|
Academic Article
|
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen.
|
Academic Article
|
The pharmacologic control of mediator release from human basophils and mast cells.
|
Academic Article
|
Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis.
|
Academic Article
|
Inflammatory mediators in nasal secretions during induced rhinitis.
|
Academic Article
|
Epithelial shedding is associated with nasal reactions to cold, dry air.
|
Academic Article
|
Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin.
|
Academic Article
|
Effect of seasonal ragweed exposure on immunoglobulin E antiragweed antibodies in cultures of peripheral mononuclear cells, plasma and nasal secretions.
|
Academic Article
|
Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys.
|
Academic Article
|
Recent advances in immunology with specific reference to otolaryngology.
|
Academic Article
|
The effect of terfenadine on unilateral nasal challenge with allergen.
|
Academic Article
|
Effect of montelukast on bacterial sinusitis in allergic mice.
|
Academic Article
|
Effect of genetic background on the response to bacterial sinusitis in mice.
|
Academic Article
|
Effects of antihistamines on inflammatory mediators.
|
Academic Article
|
In vivo human models for the study of anticholinergic drugs.
|
Academic Article
|
Observations on nasal late phase reactions.
|
Academic Article
|
Experimentally induced nasal allergic responses.
|
Academic Article
|
The role of prostaglandin D2 in IgE-mediated reactions in man.
|
Academic Article
|
Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions.
|
Academic Article
|
Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules.
|
Academic Article
|
Effect of oxymetazoline on the early response to nasal challenge with antigen.
|
Academic Article
|
Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.
|
Academic Article
|
Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis.
|
Academic Article
|
Role of human basophils and mast cells in the pathogenesis of allergic diseases.
|
Academic Article
|
Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies.
|
Academic Article
|
Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment.
|
Academic Article
|
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
|
Academic Article
|
The effect of intranasal carbon dioxide on the acute response to nasal challenge with allergen.
|
Academic Article
|
Studies on the allergic and nonallergic nasal inflammation.
|
Academic Article
|
In vivo model for the evaluation of topical antiallergic medications.
|
Academic Article
|
Basophils and eosinophils in allergic rhinitis.
|
Academic Article
|
The human nasal response to capsaicin.
|
Academic Article
|
Anatomic and physiologic considerations in sinusitis.
|
Academic Article
|
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
|
Academic Article
|
The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
|
Academic Article
|
Lack of evidence for muscarinic type 2 receptor modulation of the human nasonasal reflex.
|
Academic Article
|
Effects of a single-dose pretreatment with captopril on the immediate response to nasal challenge with allergen.
|
Academic Article
|
Effect of terfenadine on nasal provocation.
|
Academic Article
|
Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells.
|
Academic Article
|
Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper.
|
Academic Article
|
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
|
Academic Article
|
Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx.
|
Academic Article
|
The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction.
|
Academic Article
|
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells.
|
Academic Article
|
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.
|
Academic Article
|
Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms.
|
Academic Article
|
Pollen lipidomics: lipid profiling exposes a notable diversity in 22 allergenic pollen and potential biomarkers of the allergic immune response.
|
Academic Article
|
Should clinicians use omalizumab for the treatment of nasal polyps?
|
Academic Article
|
Nasal-ocular reflexes and their role in the management of allergic rhinoconjunctivitis with intranasal steroids.
|
Academic Article
|
Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.
|
Academic Article
|
Advertisements impact the physiological efficacy of a branded drug.
|
Academic Article
|
Seasonal allergic rhinitis affects sinonasal microbiota.
|
Academic Article
|
ICON: chronic rhinosinusitis.
|
Academic Article
|
Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration.
|
Academic Article
|
Consensus Definition of Nonallergic Rhinopathy, Previously Referred to as Vasomotor Rhinitis, Nonallergic Rhinitis, and/or Idiopathic Rhinitis.
|
Academic Article
|
Evidence-based approach to medical and surgical treatment of nasal polyposis.
|
Academic Article
|
Anticholinergic drugs in nonallergic rhinitis.
|
Academic Article
|
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis.
|
Academic Article
|
A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis.
|
Academic Article
|
Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis.
|
Academic Article
|
Diagnostic algorithm for unilateral sinus disease: a 15-year retrospective review.
|
Academic Article
|
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
|
Academic Article
|
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.
|
Academic Article
|
Other Phenotypes and Treatment of Chronic Rhinosinusitis.
|
Academic Article
|
Radiologic Findings in Allergic Fungal Rhinosinusitis.
|
Academic Article
|
A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge.
|
Academic Article
|
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).
|
Academic Article
|
Allergy and asthma medication use in home-dwelling U.S. older adults.
|
Academic Article
|
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.
|
Academic Article
|
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).
|
Academic Article
|
Monoclonal Antibodies for the Treatment of Nasal Polyps.
|
Academic Article
|
Nasal Polyps and Biomarkers.
|
Academic Article
|
Uncharted Waters: Challenges in the Era of Biologic Therapies for Nasal Polyposis.
|
Academic Article
|
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.
|
Academic Article
|
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project.
|
Academic Article
|
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.
|
Academic Article
|
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma.
|
Academic Article
|
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
|
Academic Article
|
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.
|
Academic Article
|
Persistence of Sinonasal Disease Despite Mepolizumab.
|
Academic Article
|
A Pragmatic Approach Towards Sinonasal Diseases.
|
Academic Article
|
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop.
|
Academic Article
|
Sinonasal Disease: An Underappreciated Entity.
|
Academic Article
|
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement.
|
Academic Article
|
International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants: Impact of air pollution on patients with AR: Current knowledge and future strategies.
|
Academic Article
|
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.
|
Academic Article
|
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.
|
Academic Article
|
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.
|
Academic Article
|
The Treatment Paradigm of Chronic Rhinosinusitis with Nasal Polyps in the COVD-19 Era.
|
Academic Article
|
Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD).
|
Academic Article
|
International consensus statement on allergy and rhinology: rhinosinusitis 2021.
|
Academic Article
|
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines.
|
Academic Article
|
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus.
|
Academic Article
|
Chronic Rhinosinusitis of Odontogenic Origin.
|
Academic Article
|
A modest proposal for a new way forward for clinical research: Involve insurance companies.
|
Academic Article
|
Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis.
|
Academic Article
|
A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012-2022.
|
Academic Article
|
Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.
|
Academic Article
|
Management of the Upper Airway Distress During Pregnancy.
|
Grant
|
INTERPLAY OF ALLERGIC RHINITIS AND NASAL HUMIDIFICATION
|
Grant
|
Allergic Rhinitis Augments Bacterial Sinusitis
|
Academic Article
|
Unblocking the Treatment Stalemate in Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP).
|